Distribution and Characteristics of Escherichia coli Clonal Group A1

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Johnson, James R. ; Murray, Andrew C. ; Kuskowski, Michael A. ; Schubert, Sören ; Prère, Marie-Francoise ; Picard, Bertrand ; Colodner, Raul ; Raz, Raul
• Corporate Authors:
  and the Trans-Global Initiative for Antimicrobial Resistance Analysis (TIARA) Investigators
• Description:
  Among 1,102 recent Escherichia coli clinical isolates, clonal group A was identified in 17 of 20 (U.S. and non-U.S.) geographic locales, mainly among U.S. isolates (9% vs. 3%; p < 0.001) and those resistant to trimethoprim-sulfamethoxazole (10% vs. 1.7%; p < 0.001). The extensive antimicrobial resistance and virulence profiles of clonal group A may underlie its recent widespread emergence.
• Subjects:
  Anti-Infective Agents Child Communicable Diseases, Emerging Dispatch Drug Resistance, Bacterial Escherichia Coli Infections Female Humans Male Microbial Sensitivity Tests Phylogeny Prevalence Trimethoprim-Sulfamethoxazole Combination Urinary Tract Infections Virulence

  More +
• Source:
  Emerg Infect Dis. 11(1):141-145.
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Location:
  North America
• Volume:
  11
• Issue:
  1
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:ec79bdade8b662c9ba01ab801ea0698fecb992d04bc10096d7ea238b8f0acdd5
• Download URL:
  https://stacks.cdc.gov/view/cdc/15616/cdc_15616_DS1.pdf
• File Type:
  [PDF - 194.73 KB ]